Mesoblast Limited (MESO) Stock Price

18.02 ▼ -0.68 (-3.64%)
Open: 18.41 Vol: 2.7K Day's range: 17.75 - 18.45 Jan 29, 15:59 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MESO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 17.93▲ 17.88▲ 17.89▲ 18.59▼ 18.59▼
MA10 17.89▲ 17.87▲ 18.15▼ 18.11▼ 18.51▼
MA20 17.86▲ 18.19▼ 18.54▼ 18.42▼ 17.50▲
MA50 17.91▲ 18.58▼ 18.33▼ 17.90▲ 14.80▲
MA100 18.36▼ 18.18▼ 18.36▼ 17.19▲ 12.04▲
MA200 18.57▼ 18.36▼ 18.56▼ 14.92▲ 7.40▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.028▲ -0.009▼ -0.112▼ -0.019▼ -0.039▼
RSI 62.253▲ 40.373▼ 39.002▼ 48.016▼ 53.909▲
STOCH 65.873     32.794     12.680▼ 68.963     63.604    
WILL %R 0.000▲ -73.000     -78.226▼ -72.050     -47.027    
CCI 166.196▲ -13.796     -63.960     -19.919     41.210    
Latest Filters Detected On MESO
RSI $MESO RSI(14) Crossed Below 50 Set Alert
▼ MACD $MESO MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $MESO Price Crossed Below MA(26) Set Alert
MA $MESO Price Crossed Below MA(13) Set Alert
MA $MESO Price Crossed Below MA(7) Set Alert
▼ GAP $MESO Open Gap Down %2 Set Alert
Mesoblast Limited News
Ryoncil® Net Revenues Increase for the Quarter to US$30M
Wednesday, January 28, 2026 04:13 PM
Ryoncil ® gross sales for the quarter were US$35 million, a 60% increase on the prior quarter ended September 30, 2025, and net revenues were US$30 million. 1 ...
Jefferies upgrades Mesoblast Limited - Depositary Receipt (MESO)
Wednesday, January 28, 2026 03:31 PM
Fintel reports that on January 22, 2026, JEFFERIES upgraded their outlook for Mesoblast Limited - Depositary Receipt (NasdaqGS:MESO) from Hold to Buy. Analyst Price Forecast Suggests 5.62% Upside As ...
Mesoblast Says Most Children Survive After Early Use Of FDA-Approved Cell Therapy For Organ Transplant Related Complication
Tuesday, January 27, 2026 09:01 AM
Mesoblast reports early real-world data showing 84% survival in children treated with FDA-approved Ryoncil, as the company expands hospital access and prepares an adult trial.
MESO historical stock data
date open high low close volume
29/01/26 18.315 18.45 17.75 18.02 176,581
28/01/26 19.19 19.205 18.48 18.70 119,489
27/01/26 18.78 19.34 18.63 19.17 180,685
26/01/26 18.38 18.72 18.38 18.68 92,304
23/01/26 18.70 18.70 18.27 18.38 107,966
22/01/26 18.09 19.00 18.09 18.77 203,329
21/01/26 16.81 17.375 16.79 17.36 284,732
20/01/26 17.10 17.15 16.67 16.83 326,301
16/01/26 17.56 17.67 17.34 17.45 148,251
15/01/26 17.96 18.024 17.69 17.73 181,974
Quote Details
52wk Low:9.61
52wk High:21.50
Vol:2.7K
Avg Vol(3m):4.3M
1Y Chng:+0.67%
1M Chng:-1.48%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.94B